> top > docs > PMC:7271924 > spans > 26189-26461 > annotations

PMC:7271924 / 26189-26461 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PMC-OGER-BB

Id Subject Object Predicate Lexical cue
T515 214-227 NCBITaxon:11118 denotes coronaviruses
T516 240-250 SP_7 denotes SARS-Cov-2
T517 263-271 SP_7 denotes COVID-19
T10854 214-227 NCBITaxon:11118 denotes coronaviruses
T63794 240-250 SP_7 denotes SARS-Cov-2
T61390 263-271 SP_7 denotes COVID-19

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
670 214-227 Species denotes coronaviruses Tax:11118
671 240-250 Species denotes SARS-Cov-2 Tax:2697049
673 263-271 Disease denotes COVID-19 MESH:C000657245

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T87 240-244 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T88 263-271 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T339 81-83 Chemical denotes LF http://purl.obolibrary.org/obo/CHEBI_73585
T340 107-109 Chemical denotes LF http://purl.obolibrary.org/obo/CHEBI_73585
T341 168-179 Chemical denotes application http://purl.obolibrary.org/obo/CHEBI_33232

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T198 0-272 Sentence denotes In view of these investigations, the authors of this paper regard enteric-coated LF as superior to regular LF supplements with respect to bioavailability and potential application for the prevention or therapy for coronaviruses such as the SARS-Cov-2 involved in COVID-19.